34.54
price down icon0.41%   -0.106
 
loading
Schlusskurs vom Vortag:
$34.65
Offen:
$34.75
24-Stunden-Volumen:
153.86K
Relative Volume:
0.08
Marktkapitalisierung:
$9.84B
Einnahmen:
$2.08B
Nettoeinkommen (Verlust:
$466.92M
KGV:
121.93
EPS:
0.2833
Netto-Cashflow:
$404.94M
1W Leistung:
-1.54%
1M Leistung:
+20.41%
6M Leistung:
+64.18%
1J Leistung:
+62.63%
1-Tages-Spanne:
Value
$34.45
$34.91
1-Wochen-Bereich:
Value
$33.82
$35.13
52-Wochen-Spanne:
Value
$19.20
$36.60

Exelixis Inc Stock (EXEL) Company Profile

Name
Firmenname
Exelixis Inc
Name
Telefon
(650) 837-7000
Name
Adresse
1851 HARBOR BAY PARKWAY, ALAMEDA, CA
Name
Mitarbeiter
1,310
Name
Twitter
@exelixisinc
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
EXEL's Discussions on Twitter

Vergleichen Sie EXEL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
EXEL 34.48 9.84B 2.08B 466.92M 404.94M 0.2833
VRTX 446.48 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.49 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.15 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.56 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.47 24.49B 3.30B -501.07M 1.03B 11.54

Exelixis Inc Stock (EXEL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-19 Eingeleitet BTIG Research Buy
2023-12-15 Eingeleitet Citigroup Buy
2023-09-26 Eingeleitet H.C. Wainwright Buy
2023-08-22 Bestätigt Oppenheimer Outperform
2023-08-08 Eingeleitet SVB Securities Market Perform
2023-07-11 Fortgesetzt Morgan Stanley Equal-Weight
2023-05-10 Fortgesetzt Piper Sandler Overweight
2023-03-09 Eingeleitet Wells Fargo Overweight
2023-01-26 Eingeleitet Credit Suisse Outperform
2022-10-18 Eingeleitet JMP Securities Mkt Outperform
2022-06-24 Eingeleitet BMO Capital Markets Outperform
2021-11-19 Eingeleitet Piper Sandler Overweight
2021-11-03 Fortgesetzt Jefferies Buy
2021-10-07 Eingeleitet Jefferies Buy
2021-08-06 Bestätigt H.C. Wainwright Buy
2021-06-15 Eingeleitet H.C. Wainwright Buy
2021-05-18 Fortgesetzt Goldman Sell
2021-03-31 Eingeleitet Credit Suisse Outperform
2021-03-12 Eingeleitet Wolfe Research Outperform
2020-03-04 Eingeleitet Barclays Overweight
2020-01-13 Eingeleitet SunTrust Buy
2019-11-13 Eingeleitet BofA/Merrill Buy
2019-03-18 Hochstufung Morgan Stanley Underweight → Equal-Weight
2018-09-17 Eingeleitet Goldman Neutral
2018-09-10 Eingeleitet Morgan Stanley Underweight
2018-05-11 Bestätigt Needham Buy
2017-10-17 Bestätigt Needham Buy
2017-10-17 Bestätigt RBC Capital Mkts Outperform
2017-10-16 Bestätigt SunTrust Buy
2017-09-22 Herabstufung Leerink Partners Outperform → Mkt Perform
2017-09-15 Eingeleitet RBC Capital Mkts Outperform
2017-09-12 Bestätigt Needham Buy
2017-07-14 Eingeleitet SunTrust Buy
2017-03-31 Eingeleitet Needham Buy
2017-03-16 Eingeleitet Oppenheimer Perform
2017-02-28 Herabstufung Stifel Buy → Hold
2016-11-03 Eingeleitet Deutsche Bank Buy
2016-10-10 Hochstufung Piper Jaffray Neutral → Overweight
2016-09-15 Bestätigt Stifel Buy
Alle ansehen

Exelixis Inc Aktie (EXEL) Neueste Nachrichten

pulisher
06:10 AM

Ontario Teachers Pension Plan Board Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

06:10 AM
pulisher
Nov 20, 2024

EULAV Asset Management Sells 45,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Thyroid Cancer Therapeutics Market May See a Big Move| Pfizer, Exelixis, AbbVie - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity - Yahoo Finance

Nov 20, 2024
pulisher
Nov 19, 2024

Exelixis exec Haley Patrick sells $1.43 million in stock By Investing.com - Investing.com Australia

Nov 19, 2024
pulisher
Nov 19, 2024

Exelixis exec Haley Patrick sells $1.43 million in stock - Investing.com

Nov 19, 2024
pulisher
Nov 18, 2024

Janney Montgomery Scott LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Exelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Seizert Capital Partners LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

1 No-Brainer Stock to Buy With $40 - AOL

Nov 17, 2024
pulisher
Nov 16, 2024

Cornercap Investment Counsel Inc. Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

18,300 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Entropy Technologies LP - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Exelixis, Inc. (NASDAQ:EXEL) Receives $31.44 Consensus Target Price from Analysts - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Principal Financial Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 15, 2024
pulisher
Nov 13, 2024

Here's Why Exelixis (EXEL) is a Strong Momentum Stock - MSN

Nov 13, 2024
pulisher
Nov 12, 2024

CWA Asset Management Group LLC Invests $577,000 in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Here's Why Exelixis (EXEL) is a Strong Value Stock - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now? - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Here is Why Growth Investors Should Buy Exelixis (EXEL) Now - MSN

Nov 11, 2024
pulisher
Nov 10, 2024

Los Angeles Capital Management LLC Has $46.47 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Van ECK Associates Corp Boosts Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Have Insiders Sold Exelixis Shares Recently? - Simply Wall St

Nov 08, 2024
pulisher
Nov 08, 2024

Exelixis CSO Aftab Dana sells $3.39 million in stock - Investing.com

Nov 08, 2024
pulisher
Nov 07, 2024

Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

Exelixis CSO Aftab Dana sells $3.39 million in stock By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Exelixis to shed 212K sf of industrial in Alameda - The Real Deal

Nov 07, 2024
pulisher
Nov 07, 2024

Robeco Institutional Asset Management B.V. Purchases 350,026 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Exelixis stock soars to 52-week high, reaches $35.76 - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Exelixis's SWOT analysis: oncology leader's stock poised for growth By Investing.com - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

Exelixis EVP sells $1.7 million in stock - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis EVP sells $1.7 million in stock By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis director George Poste sells $1.02 million in shares - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis director George Poste sells $1.02 million in shares By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Earnings Estimates Rising for Exelixis (EXEL): Will It Gain? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis (NASDAQ:EXEL) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Capital Management Corp VA - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Exelixis's SWOT analysis: oncology leader's stock poised for growth - Investing.com India

Nov 05, 2024
pulisher
Nov 04, 2024

Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Exelixis (EXEL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Nov 04, 2024
pulisher
Nov 03, 2024

3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool

Nov 03, 2024
pulisher
Nov 03, 2024

New York State Teachers Retirement System Purchases 20,008 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Dana Aftab Sells 1,162 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis cso sells stock worth $36,486 - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis (NASDAQ:EXEL) Issues Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Trend Tracker for (EXEL) - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Exelixis price target raised to $38 from $33 at Truist - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Stephens Investment Management Group LLC Has $98.78 Million Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Exelixis stock hits 52-week high at $31.3 amid robust growth - Investing.com Australia

Oct 31, 2024

Finanzdaten der Exelixis Inc-Aktie (EXEL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):